moclobemide and ro 12-8095

moclobemide has been researched along with ro 12-8095 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chavinie, J; Francoual, C; Moran, C; Olive, G; Pedarriosse, AM; Pfefen, JP; Pons, G; Schoerlin, MP; Tam, YK1
Brøsen, K; Gram, LF1
Bae, KS; Cho, JY; Jang, IJ; Lee, KH; Park, JY; Park, SS; Shin, SG; Yi, SY; Yim, DS; Yu, KS1
Gross, AS; Hoskins, JM; Rivory, LP; Shenfield, GM1
Miljkovic, B; Pokrajac, M; Rakic, A; Vucicevic, K1

Trials

2 trial(s) available for moclobemide and ro 12-8095

ArticleYear
Moclobemide treatment causes a substantial rise in the sparteine metabolic ratio. Danish University Antidepressant Group.
    British journal of clinical pharmacology, 1993, Volume: 35, Issue:6

    Topics: Adult; Aged; Benzamides; Cimetidine; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Debrisoquin; Female; Humans; Male; Middle Aged; Mixed Function Oxygenases; Moclobemide; Monoamine Oxidase Inhibitors; Morpholines; Oxidation-Reduction; Phenotype; Polymorphism, Genetic; Single-Blind Method; Sparteine

1993
Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19.
    Clinical pharmacology and therapeutics, 2001, Volume: 69, Issue:4

    Topics: Adult; Antidepressive Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Benzamides; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Genotype; Humans; Mixed Function Oxygenases; Moclobemide; Morpholines; Omeprazole; Polymorphism, Genetic; Random Allocation

2001

Other Studies

3 other study(ies) available for moclobemide and ro 12-8095

ArticleYear
Moclobemide excretion in human breast milk.
    British journal of clinical pharmacology, 1990, Volume: 29, Issue:1

    Topics: Adult; Benzamides; Biological Availability; Biotransformation; Female; Humans; Milk, Human; Moclobemide; Monoamine Oxidase Inhibitors; Morpholines

1990
High-performance liquid chromatography-electrospray ionization mass spectrometry method for the measurement of moclobemide and two metabolites in plasma.
    Journal of chromatography. B, Biomedical sciences and applications, 2001, Apr-25, Volume: 754, Issue:2

    Topics: Antidepressive Agents; Benzamides; Chromatography, High Pressure Liquid; Drug Stability; Humans; Moclobemide; Morpholines; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization

2001
High-performance liquid chromatographic method for the determination of moclobemide and its two major metabolites in human plasma.
    Journal of pharmaceutical and biomedical analysis, 2007, Mar-12, Volume: 43, Issue:4

    Topics: Benzamides; Blood; Chromatography, High Pressure Liquid; Humans; Moclobemide; Molecular Structure; Morpholines; Sensitivity and Specificity; Spectrophotometry, Ultraviolet

2007